Hospitalized patients and stimulant use-associated heart failure: importance of ejection fraction and related risk factors.
Saved in:
| Title: | Hospitalized patients and stimulant use-associated heart failure: importance of ejection fraction and related risk factors. |
|---|---|
| Authors: | Agrawal A; Department of Public Health, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States., Scardino B; Department of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States., Xing DG; Department of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States., Bhuiyan MS; Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States.; Department of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States., Bevins RA; Department of Psychology, University of Nebraska-Lincoln, Lincoln, NE, United States., Modi K; Department of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States., Helmy T; Department of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States., Conrad SA; Department of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States.; Department of Pediatrics, LSU Health Sciences Center at Shreveport, Shreveport, LA, United States., Goeders NE; Department of Pharmacology, Toxicology & Neuroscience, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States., Bhuiyan MMR; Department of Pediatric Cardiology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh., Vanchiere JA; Department of Pediatrics, LSU Health Sciences Center at Shreveport, Shreveport, LA, United States.; Department of Pharmacology, Toxicology & Neuroscience, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States., Orr AW; Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States.; Department of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States., Kevil CG; Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States.; Department of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States., Bhuiyan MAN; Department of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States.; Department of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States.; Louisiana Addiction Research Center, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States. |
| Source: | Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2025 Jul 03; Vol. 12, pp. 1566481. Date of Electronic Publication: 2025 Jul 03 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653388 Publication Model: eCollection Cited Medium: Print ISSN: 2297-055X (Print) Linking ISSN: 2297055X NLM ISO Abbreviation: Front Cardiovasc Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2297-055X |
|---|---|
| DOI: | 10.3389/fcvm.2025.1566481 |
